STOCK TITAN

Molecular Templates to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Molecular Templates, Inc. (Nasdaq: MTEM) has announced a corporate update and will participate in 1-on-1 investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference on July 13-14, 2021. The presentation is scheduled for Tuesday, July 13, 2021, at 4:00 PM ET. Investors can access a live webcast of the presentation on the MTEM website, with a replay available afterward. The company focuses on developing engineered toxin bodies (ETBs), aimed at providing targeted therapeutics for cancer and other serious diseases.

Positive
  • None.
Negative
  • None.

AUSTIN, Texas, July 06, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that it will provide a corporate update and participate in 1-on-1 investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference, to take place July 13-14, 2021.

Presentation details can be found below.

Date:Tuesday, July 13, 2021
Time:4:00 PM ET

A live webcast of the presentation will be available in the “News and Events” section of the MTEM website at www.mtem.com. Additionally, a replay of the webcast will be available on MTEM’s website following the conference. 

About Molecular Templates
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Molecular Templates, Inc.


FAQ

What is Molecular Templates planning for the Ladenburg Thalmann Healthcare Conference on July 13-14, 2021?

Molecular Templates will provide a corporate update and participate in 1-on-1 investor meetings at the Ladenburg Thalmann Healthcare Conference.

When will Molecular Templates present at the Ladenburg Thalmann Conference?

Molecular Templates will present on Tuesday, July 13, 2021, at 4:00 PM ET.

Where can I watch the live presentation of Molecular Templates at the conference?

The live presentation can be viewed on the Molecular Templates website in the 'News and Events' section.

What is the focus of Molecular Templates, Inc.?

Molecular Templates is focused on the discovery and development of engineered toxin bodies (ETBs) for targeted cancer therapeutics.

What technology does Molecular Templates utilize for its drug development?

Molecular Templates uses engineered toxin bodies (ETBs) technology to create novel therapies for serious diseases.

Molecular Templates, Inc.

NASDAQ:MTEM

MTEM Rankings

MTEM Latest News

MTEM Stock Data

2.41M
6.32M
3.96%
35.01%
4.1%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
AUSTIN